Literature DB >> 7515147

ErbB3 is involved in activation of phosphatidylinositol 3-kinase by epidermal growth factor.

S P Soltoff1, K L Carraway, S A Prigent, W G Gullick, L C Cantley.   

Abstract

Conflicting results concerning the ability of the epidermal growth factor (EGF) receptor to associate with and/or activate phosphatidylinositol (PtdIns) 3-kinase have been published. Despite the ability of EGF to stimulate the production of PtdIns 3-kinase products and to cause the appearance of PtdIns 3-kinase activity in antiphosphotyrosine immunoprecipitates in several cell lines, we did not detect EGF-stimulated PtdIns 3-kinase activity in anti-EGF receptor immunoprecipitates. This result is consistent with the lack of a phosphorylated Tyr-X-X-Met motif, the p85 Src homology 2 (SH2) domain recognition sequence, in this receptor sequence. The EGF receptor homolog, ErbB2 protein, also lacks this motif. However, the ErbB3 protein has seven repeats of the Tyr-X-X-Met motif in the carboxy-terminal unique domain. Here we show that in A431 cells, which express both the EGF receptor and ErbB3, PtdIns 3-kinase coprecipitates with the ErbB3 protein (p180erbB3) in response to EGF. p180erbB3 is also shown to be tyrosine phosphorylated in response to EGF. In contrast, a different mechanism for the activation of PtdIns 3-kinase in response to EGF occurs in certain cells (PC12 and A549 cells). Thus, we show for the first time that ErbB3 can mediate EGF responses in cells expressing both ErbB3 and the EGF receptor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7515147      PMCID: PMC358722          DOI: 10.1128/mcb.14.6.3550-3558.1994

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  46 in total

1.  Evidence for two distinct phosphatidylinositol kinases in fibroblasts. Implications for cellular regulation.

Authors:  M Whitman; D Kaplan; T Roberts; L Cantley
Journal:  Biochem J       Date:  1987-10-01       Impact factor: 3.857

Review 2.  Growth factor receptor tyrosine kinases.

Authors:  Y Yarden; A Ullrich
Journal:  Annu Rev Biochem       Date:  1988       Impact factor: 23.643

Review 3.  After insulin binds.

Authors:  O M Rosen
Journal:  Science       Date:  1987-09-18       Impact factor: 47.728

4.  PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells.

Authors:  K R Auger; L A Serunian; S P Soltoff; P Libby; L C Cantley
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

5.  Epidermal growth factor stimulates tyrosine phosphorylation of phospholipase C-II independently of receptor internalization and extracellular calcium.

Authors:  M I Wahl; S Nishibe; P G Suh; S G Rhee; G Carpenter
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

6.  Phospholipase C-gamma is a substrate for the PDGF and EGF receptor protein-tyrosine kinases in vivo and in vitro.

Authors:  J Meisenhelder; P G Suh; S G Rhee; T Hunter
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

7.  EGF induces tyrosine phosphorylation of phospholipase C-II: a potential mechanism for EGF receptor signaling.

Authors:  B Margolis; S G Rhee; S Felder; M Mervic; R Lyall; A Levitzki; A Ullrich; A Zilberstein; J Schlessinger
Journal:  Cell       Date:  1989-06-30       Impact factor: 41.582

8.  Separation and characterization of a phosphatidylinositol kinase activity that co-purifies with the epidermal growth factor receptor.

Authors:  D M Thompson; C Cochet; E M Chambaz; G N Gill
Journal:  J Biol Chem       Date:  1985-07-25       Impact factor: 5.157

9.  Epidermal growth factor stimulates the production of phosphatidylinositol monophosphate and the breakdown of polyphosphoinositides in A431 cells.

Authors:  L J Pike; A T Eakes
Journal:  J Biol Chem       Date:  1987-02-05       Impact factor: 5.157

10.  Egf binding to its receptor triggers a rapid tyrosine phosphorylation of the erbB-2 protein in the mammary tumor cell line SK-BR-3.

Authors:  C R King; I Borrello; F Bellot; P Comoglio; J Schlessinger
Journal:  EMBO J       Date:  1988-06       Impact factor: 11.598

View more
  194 in total

1.  The C-terminus of the kinase-defective neuregulin receptor ErbB-3 confers mitogenic superiority and dictates endocytic routing.

Authors:  H Waterman; I Alroy; S Strano; R Seger; Y Yarden
Journal:  EMBO J       Date:  1999-06-15       Impact factor: 11.598

Review 2.  Roles of ErbB-3 and ErbB-4 in the physiology and pathology of the mammary gland.

Authors:  K L Carraway; C A Carraway; K L Carraway
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

Review 3.  ErbB receptors and EGF-like ligands: cell lineage determination and oncogenesis through combinatorial signaling.

Authors:  R Pinkas-Kramarski; I Alroy; Y Yarden
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-04       Impact factor: 2.673

4.  Phosphatidylinositol 3-kinase-dependent activation of trypsinogen modulates the severity of acute pancreatitis.

Authors:  V P Singh; A K Saluja; L Bhagat; G J van Acker; A M Song; S P Soltoff; L C Cantley; M L Steer
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

5.  Role of PI 3-kinase and PIP3 in submandibular gland branching morphogenesis.

Authors:  Melinda Larsen; Matthew P Hoffman; Takayoshi Sakai; Justin C Neibaur; Jonathan M Mitchell; Kenneth M Yamada
Journal:  Dev Biol       Date:  2003-03-01       Impact factor: 3.582

6.  Pertuzumab plus trastuzumab plus docetaxel for metastatic breast cancer.

Authors:  José Baselga; Javier Cortés; Sung-Bae Kim; Seock-Ah Im; Roberto Hegg; Young-Hyuck Im; Laslo Roman; José Luiz Pedrini; Tadeusz Pienkowski; Adam Knott; Emma Clark; Mark C Benyunes; Graham Ross; Sandra M Swain
Journal:  N Engl J Med       Date:  2011-12-07       Impact factor: 91.245

7.  Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation.

Authors:  K Elenius; S Paul; G Allison; J Sun; M Klagsbrun
Journal:  EMBO J       Date:  1997-03-17       Impact factor: 11.598

8.  ErbB-2, the preferred heterodimerization partner of all ErbB receptors, is a mediator of lateral signaling.

Authors:  D Graus-Porta; R R Beerli; J M Daly; N E Hynes
Journal:  EMBO J       Date:  1997-04-01       Impact factor: 11.598

9.  ERBB3: Multifunctional enabler or primary actor in pancreatic cancer?

Authors:  Ralf Landgraf
Journal:  Cancer Biol Ther       Date:  2010-09-13       Impact factor: 4.742

Review 10.  Molecular pathways: HER3 targeted therapy.

Authors:  Kinisha Gala; Sarat Chandarlapaty
Journal:  Clin Cancer Res       Date:  2014-02-11       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.